Skip to main content
SpringerLink
Log in

Scabies Outbreaks in Nursing Homes for the Elderly

Recognition, Treatment Options and Control of Reinfestation

  • Therapy In Practice
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

The scabies mite is an ectoparasite able to infest humans. Its clinical presentation is typical, although in immunocompromised, mentally retarded and elderly patients the clinical presentation may be altered. Diagnosis may therefore be difficult in such patient groups, who often reside in nursing homes. Because delay in diagnosis may induce rapid spread of the scabies mite, immediate diagnosis and treatment are necessary. Normal scabies (scabies vulgaris) and crusted scabies (scabies crustosa, scabies norvegica), although sometimes difficult to diagnose, especially in the elderly, are fortunately quite easy to treat. However, the elderly patient may experience toxicity from local or systemic scabicidal treatment. Single cases of scabies vulgaris should be treated with permethrin cream because of its outstanding efficacy and favourable adverse events profile. Scabies outbreaks and cases of scabies crustosa can easily be managed using combination therapy consisting of topical application of permethrin and two oral doses of ivermectin 200 µg/kg (administered 1 week apart). In addition to treatment of the scabies infestation, preventative measures are necessary, particularly in nursing homes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I
Table II
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Holness DL, DeKoven JG, Nethercott JR. Scabies in chronic health care institutions. Arch Dermatol 1992; 128: 1257–60

    Article  PubMed  CAS  Google Scholar 

  2. Koene RP, Tjioe M, Hoondert K, et al. Scabies outbreak in a hospital and in 8 health-care institutions caused by an elderly patient with scabies crustosa [in Dutch]. Ned Tijdschr Geneeskd 2006; 150: 918–23

    PubMed  CAS  Google Scholar 

  3. Tan HH, Goh CL. Parasitic skin infections in the elderly: recognition and drug treatment. Drugs Aging 2001; 18: 165–76

    Article  PubMed  CAS  Google Scholar 

  4. Burgess I. Sarcoptes scabiei and scabies. Adv Parasitol 1994; 33: 235–92

    Article  PubMed  CAS  Google Scholar 

  5. Haag ML, Brozena SJ, Fenske NA. Attack of the scabies: what to do when an outbreak occurs. Geriatrics 1993; 48: 45–3

    PubMed  CAS  Google Scholar 

  6. Arlian LG, Runyan RA, Achar S, et al. Survival and infectivity of Sarcoptes scabiei var. canis and var. hominis. J Am Acad Dermatol 1984; 11: 210–5

    Article  PubMed  CAS  Google Scholar 

  7. Arlian LG. Biology, host relations, and epidemiology of Sarcoptes scabiei. Annu Rev Entomol 1989; 34: 139–61

    Article  PubMed  CAS  Google Scholar 

  8. Hengge UR, Currie BJ, Jager G, et al. Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis 2006; 6: 769–79

    Article  PubMed  Google Scholar 

  9. Sunderkotter C, Mayser P, Folster-Holst R, et al. Scabies. J Dtsch Dermatol Ges 2007; 5: 424–30

    Article  PubMed  Google Scholar 

  10. Chosidow O. Scabies and pediculosis. Lancet 2000; 355: 819–26

    Article  PubMed  CAS  Google Scholar 

  11. Scott FP, Lups JG. Scabies: a historical review and description of a case of scabies norvegica. S Afr Med J 1970; 44: 66–9

    PubMed  CAS  Google Scholar 

  12. Roberts LJ, Huffam SE, Walton SF, et al. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect 2005; 50: 375–81

    Article  PubMed  CAS  Google Scholar 

  13. O’Donnell BF, O’Loughlin S, Powell FC. Management of crusted scabies. Int J Dermatol 1990; 29: 258–66

    Article  PubMed  Google Scholar 

  14. Savin JA. Scabies in Edinburgh from 1815 to 2000. J Soc Med 2005; 98: 124–9

    Article  CAS  Google Scholar 

  15. Mimouni D, Ankol OE, Davidovitch N, et al. Seasonality trends of scabies in a young adult population: a 20-year follow-up. Br J Dermatol 2003; 149: 157–9

    Article  PubMed  CAS  Google Scholar 

  16. Badiaga S, Menard A, Tissot DH, et al. Prevalence of skin infections in sheltered homeless. Eur J Dermatol 2005; 15: 382–6

    PubMed  Google Scholar 

  17. Walton SF, McBroom J, Mathews JD, et al. Crusted scabies: a molecular analysis of Sarcoptes scabiei variety hominis populations from patients with repeated infestations. Clin Infect Dis 1999; 29: 1226–30

    Article  PubMed  CAS  Google Scholar 

  18. Tsutsumi M, Nishiura H, Kobayashi T. Dementia-specific risks of scabies: retrospective epidemiologic analysis of an unveiled nosocomial outbreak in Japan from 1989–90. BMC Infect Dis 2005; 5: 85

    Article  PubMed  Google Scholar 

  19. Savin JA. Mellanby on scabies. Clin Exp Dermatol 2002; 27: 86–7

    Article  PubMed  CAS  Google Scholar 

  20. Gimenez GR, de la Lama Lopez-Areal J, Avellaneda MC. Scabies in the elderly. J Eur Acad Dermatol Venereol 2004; 18: 105–7

    Article  Google Scholar 

  21. Dupuy A, Dehen L, Bourrat E, et al. Accuracy of standard dermoscopy for diagnosing scabies. J Am Acad Dermatol 2007; 56: 53–62

    Article  PubMed  Google Scholar 

  22. Katsumata K, Katsumata K. Simple method of detecting Sarcoptes scabiei var hominis mites among bedridden elderly patients suffering from severe scabies infestation using an adhesive-tape. Intern Med 2006; 45: 857–9

    Article  PubMed  Google Scholar 

  23. Woodley D, Saurat JH. The burrow ink test and the scabies mite. J Am Acad Dermatol 1981; 4: 715–22

    Article  PubMed  CAS  Google Scholar 

  24. Strong M, Johnstone P. Interventions for treating scabies. Cochrane Database Syst Rev 2007; 3: CD000320

    PubMed  Google Scholar 

  25. Boffa MJ, Brough PA, Ead RD. Lindane neurotoxicity [letter]. Br J Dermatol 1995; 133: 1013

    Article  PubMed  CAS  Google Scholar 

  26. Friedman GD. Lindane and cancer in humans: a false alarm? Pharmacoepidemiol Drug Saf 1997; 6(2): 129–34

    Article  PubMed  CAS  Google Scholar 

  27. Katsumata K, Katsumata K. Norwegian scabies in an elderly patient who died after treatment with gammaBHC. Intern Med 2003; 42: 367–9

    Article  PubMed  Google Scholar 

  28. Coleman CI, Gillespie EL, White CM. Probable topical permethrin-induced neck dystonia. Pharmacotherapy 2005; 25: 448–50

    Article  PubMed  Google Scholar 

  29. Moeller HC, Rider JA. Plasma and red blood cell cholinesterase activity as indications of the threshold of incipient toxicity of ethyl-p-nitrophenyl thionobenzenephosphonate (EPN) and malathion in human beings. Toxicol Appl Pharmacol 1962; 4: 123–30

    Article  PubMed  CAS  Google Scholar 

  30. Taplin D, Meinking TL, Chen JA, et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatr Dermatol 1990; 7: 67–73

    Article  PubMed  CAS  Google Scholar 

  31. Leppard B, Naburi AE. The use of ivermectin in controlling an outbreak of scabies in a prison. Br J Dermatol 2000; 143: 520–3

    Article  PubMed  CAS  Google Scholar 

  32. Chouela EN, Abeldano AM, Pellerano G, et al. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies. Arch Dermatol 1999; 135: 651–5

    Article  PubMed  CAS  Google Scholar 

  33. Glaziou P, Cartel JL, Alzieu P, et al. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop Med Parasitai 1993; 44: 331–2

    CAS  Google Scholar 

  34. Meinking TL, Taplin D, Hermida JL, et al. The treatment of scabies with ivermectin. N Engl J Med 1995; 333: 26–30

    Article  PubMed  CAS  Google Scholar 

  35. Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies. Lancet 1997; 349: 1144–5

    Article  PubMed  CAS  Google Scholar 

  36. Bredal WP. Deaths associated with ivermectin for scabies [letter]. Lancet 1997; 350: 216

    Article  PubMed  CAS  Google Scholar 

  37. Coyne PE, Addiss DG. Deaths associated with ivermectin for scabies. Lancet 1997; 350: 215–6

    Article  PubMed  CAS  Google Scholar 

  38. Diazgranados JA, Costa JL. Deaths after ivermectin treatment [letter]. Lancet 1997; 349: 1698

    Article  PubMed  CAS  Google Scholar 

  39. Reintjes R, Hoek C. Deaths associated with ivermectin for scabies [letter]. Lancet 1997; 350: 215

    Article  PubMed  CAS  Google Scholar 

  40. Santoro AF, Rezac MA, Lee JB. Current trend in ivermectin usage for scabies. J Drugs Dermatol 2003; 2(4): 397–401

    PubMed  Google Scholar 

  41. Tomalik-Scharte D, Lazar A, Meins J, et al. Dermal absorption of permethrin following topical administration. Eur J Clin Pharmacol 2005; 61: 399–404

    Article  PubMed  CAS  Google Scholar 

  42. Guldbakke KK, Khachemoune A. Crusted scabies: a clinical review. J Drugs Dermatol 2006; 5: 221–7

    PubMed  Google Scholar 

  43. Oladimeji FA, Orafidiya OO, Ogunniyi TA, et al. Pediculocidal and scabicidal properties of Lippia multiflora essential oil. J Ethnopharmacol 2000; 72: 305–11

    Article  PubMed  CAS  Google Scholar 

  44. Walton SF, McKinnon M, Pizzutto S, et al. Acaricidal activity of Melaleuca altemifolia (tea tree) oil: in vitro sensitivity of Sarcoptes scabiei var hominis to terpinen-4-ol. Arch Dermatol 2004; 140: 563–6

    Article  PubMed  CAS  Google Scholar 

  45. Tarigan S, Huntley JF. Failure to protect goats following vaccination with soluble proteins of Sarcoptes scabiei: evidence for a role for IgE antibody in protection. Vet Parasitol 2005; 133: 101–9

    Article  PubMed  CAS  Google Scholar 

  46. Walton SF, Choy JL, Bonson A, et al. Genetically distinct dog-derived and human-derived Sarcoptes scabiei in scabies-endemic communities in northern Australia. Am J Trop Med Hyg 1999; 61: 542–7

    PubMed  CAS  Google Scholar 

  47. Witkowski JA, Parish LC. Lindane-resistant scabies [letter]. J Am Acad Dermatol 1992; 27: 648

    Article  PubMed  CAS  Google Scholar 

  48. Currie BJ, Harumal P, McKinnon M, et al. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis 2004; 39: e8–12

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this article. The authors have no conflicts of interest that are directly relevant to the content of this article.

Author information

Authors and Affiliations

  1. Department of Dermatology, Gelre Hospitals, PO Box 9014, NL-7300 DS, Apeldoorn, the Netherlands

    Milan Tjioe

  2. Department of Dermatology, Radboud University Medical Centre, Nijmegen, the Netherlands

    Wynand H. P. M. Vissers

Authors
  1. Milan Tjioe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wynand H. P. M. Vissers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Milan Tjioe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tjioe, M., Vissers, W.H.P.M. Scabies Outbreaks in Nursing Homes for the Elderly. Drugs Aging 25, 299–306 (2008). https://doi.org/10.2165/00002512-200825040-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200825040-00003

Keywords

Search

Navigation